12. COVID-19 and Cardiology

COVID-19 can lead to myocardial injury, which refers to damage to the heart muscle. This can occur due to direct viral invasion, systemic inflammation, oxygen supply-demand mismatch, or other mechanisms. Myocardial injury may manifest as elevated cardiac biomarkers (e.g., troponin) and can lead to acute cardiac events, including heart attacks, heart failure, or arrhythmias. Impact on Cardiac Services and Elective Procedures: During the peak of the pandemic, many hospitals had to prioritize COVID-19 patients and allocate resources accordingly. This led to the postponement or cancellation of elective cardiac procedures, such as diagnostic tests, interventions, and surgeries


    Related Conference of 12. COVID-19 and Cardiology

    November 26-27, 2024

    4th World Congress on Surgery

    Zurich, Switzerland
    November 28-29, 2024

    15th European Conference on Surgery & Cosmetology

    Paris, France
    December 02-03, 2024

    7th Annual Summit on Surgery and Transplantation

    Prague, Czech Republic
    February 24-25, 2025

    11th International Conference on Surgeons

    Madrid, Spain
    May 19-20, 2025

    10th International Conference on Surgery and Anaesthesia

    Zurich, Switzerland

    12. COVID-19 and Cardiology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in